|
|
|
| From solubility challenges to modified release and pediatric dosage forms, we help sponsors overcome development roadblocks with tailored, scalable solutions. We combine formulation and manufacturing expertise with a sponsor-informed mindset that keeps clinical, regulatory, and commercial goals in focus. At AustinPx, we don’t rely on generic approaches. We collaborate across disciplines to build scientifically sound, strategically aligned formulations. This is where complex challenges meet tailored solutions and where your molecule finds a path that delivers. |
|
|
|
|
|
Transitioning Your Product In Clinical Studies | White Paper | Upperton Pharma Solutions | Strategic partnerships can streamline your transition from Phase 1 to Phase 2 clinical studies, ensuring optimized dosage forms, seamless scale-up, and alignment with patient and study requirements. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | A perennial outsourcing problem has resurfaced, according to industry sources. It is the misalignment at CDMOs between their business development and tech ops or other project-evaluation teams. Sponsors are again encountering situations where CDMO sales/BD show enthusiasm, but later hear the project has been declined. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
Removing The Headache | Webinar | Cambrex | Should you manage certain operations internally or partner with a trusted external provider? Watch experts discuss the benefits of outsourcing stability, storage, and testing. |
|
|
|
|
Pull Your Fill/Finish Line Closer | Resilience US, Inc. | Learn how partnering with us gives you access to our unique, interconnected network, purpose-built to overcome the breakpoints common in traditional manufacturing models. |
|
|
AI-Enabled Route Scouting Service | Lonza | Observe how we are empowering biotech partners to overcome the complexities of API development and bring life-changing medicines to market faster. |
|
|
Capacity Update October 2024: Fill/Finish | PCI Pharma Services | Jeff Clement, Executive Director of Technical Sales Drug Product Development and Manufacturing, outlines our global sterile fill-finish and lyophilization capabilities, investments, and expansions. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
